The FDA’s draft guidance on CBD enforcement policy was submitted for review by the White House Office of Management and Budget (OMB) and the OMB has now scheduled meetings with various hemp/CBD stakeholder groups
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields